168 related articles for article (PubMed ID: 17391729)
1. 14-3-3sigma negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma.
Kuroda Y; Aishima S; Taketomi A; Nishihara Y; Iguchi T; Taguchi K; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Jul; 38(7):1014-1022. PubMed ID: 17391729
[TBL] [Abstract][Full Text] [Related]
2. Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor.
Suzuki T; Urano T; Miki Y; Moriya T; Akahira J; Ishida T; Horie K; Inoue S; Sasano H
Cancer Sci; 2007 May; 98(5):644-51. PubMed ID: 17359284
[TBL] [Abstract][Full Text] [Related]
3. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome.
Jarnagin WR; Klimstra DS; Hezel M; Gonen M; Fong Y; Roggin K; Cymes K; DeMatteo RP; D'Angelica M; Blumgart LH; Singh B
J Clin Oncol; 2006 Mar; 24(7):1152-60. PubMed ID: 16505435
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3σ downregulation suppresses ICC metastasis via impairing migration, invasion, and anoikis resistance of ICC cells.
Yang Z; Jin Q; Hu W; Dai L; Xue Z; Man D; Zhou L; Xie H; Wu J; Zheng S
Cancer Biomark; 2017 Jul; 19(3):313-325. PubMed ID: 28482619
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
Lee CT; Wu TT; Lohse CM; Zhang L
Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
[TBL] [Abstract][Full Text] [Related]
7. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma.
Kang YK; Kim WH; Jang JJ
Hum Pathol; 2002 Sep; 33(9):877-83. PubMed ID: 12378511
[TBL] [Abstract][Full Text] [Related]
8. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
Wang X; Zhang J; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
[TBL] [Abstract][Full Text] [Related]
9. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M
Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985
[TBL] [Abstract][Full Text] [Related]
10. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of 14-3-3sigma by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front.
Ide M; Nakajima T; Asao T; Kuwano H
Cancer Lett; 2004 Apr; 207(2):241-9. PubMed ID: 15072834
[TBL] [Abstract][Full Text] [Related]
13. Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.
Li Z; Dong Z; Myer D; Yip-Schneider M; Liu J; Cui P; Schmidt CM; Zhang JT
BMC Cancer; 2010 Nov; 10():598. PubMed ID: 21040574
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive analysis of immunohistochemical studies in intrahepatic cholangiocarcinoma using the survival tree model.
Iguchi T; Yamashita N; Aishima S; Kuroda Y; Terashi T; Sugimachi K; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Oncology; 2009; 76(4):293-300. PubMed ID: 19262069
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological and prognostic impact of 14-3-3 protein isoforms expression in human cholangiocarcinoma by immunohistochemistry.
Wu Q; Liu CZ; Tao LY; Yu L; Liu W; Chen SS; He XD
Asian Pac J Cancer Prev; 2012; 13(4):1253-9. PubMed ID: 22799314
[TBL] [Abstract][Full Text] [Related]
16. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
17. The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma.
Sugimachi K; Aishima S; Taguchi K; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
J Hepatol; 2001 Jul; 35(1):74-9. PubMed ID: 11495045
[TBL] [Abstract][Full Text] [Related]
18. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Zhao P; Lu Y; Zhong M; Liu L; Li B
Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma.
Aishima S; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Mod Pathol; 2008 Mar; 21(3):256-64. PubMed ID: 18192971
[TBL] [Abstract][Full Text] [Related]
20. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
